TMEM45A and hepatocellular carcinoma: In this study, we fabricated a novel, highly robust four-gene marker (including PON1, FTCD, G6PD, and TMEM45A) for the prediction of HCC prognosis, based on EMT-associated genes, and validated the marker in two other independent cohorts.